AGEWISE: Unravelling the Gut-Hormone Axis in Women's Ageing

Recruiting now

Conditions studied: Menopause, Gut Microbiome, Hormonal Changes, Chronic Low-Grade Inflammation, Inflammaging

In brief

AGEWISE is an observational study that aims to understand how changes in gut microbiome are related to hormonal changes during women's ageing, particularly across the different stages of menopause. The study will include healthy women aged 40 to 64 years living in Portugal, who will provide stool and blood samples and complete questionnaires about their health, lifestyle, diet, and menopausal symptoms. Researchers will study the gut microbiome together with hormone levels and markers of inflammation to better understand how menopause affects long-term health and to support the development of improved prevention strategies for women.

Key facts

Study ID
NCT07614542
Run by
Gulbenkian Institute for Molecular Medicine
People needed
300
Starts
2025-06-02
Expected to finish
2036-12-01
Last updated by the study team
2026-05-29

Who can join

Age: 40 and older, up to 64. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.